Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
dabigatran vs warfarin bleeding risk | 1.52 | 0.6 | 8864 | 97 | 36 |
dabigatran | 0.65 | 0.6 | 5084 | 73 | 10 |
vs | 1.85 | 0.6 | 6250 | 58 | 2 |
warfarin | 0.67 | 0.3 | 4697 | 91 | 8 |
bleeding | 0.15 | 0.5 | 3753 | 64 | 8 |
risk | 0.38 | 0.4 | 6947 | 89 | 4 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
dabigatran vs warfarin bleeding risk | 0.42 | 0.2 | 9721 | 30 |
does dabigatran increase risk of bleeding | 1.41 | 0.2 | 7138 | 29 |
dabigatran vs apixaban bleeding risk | 0.27 | 1 | 5754 | 95 |
switching from warfarin to dabigatran | 1.71 | 0.1 | 3754 | 16 |
dabigatran to warfarin conversion | 1.2 | 0.9 | 545 | 79 |
dabigatran is an anticoagulant | 1.94 | 0.6 | 673 | 30 |
dabigatran type of anticoagulant | 1.41 | 1 | 9042 | 73 |
doac vs warfarin bleeding risk | 1.25 | 0.7 | 8662 | 47 |
direct oral anticoagulants vs warfarin | 0.13 | 1 | 8217 | 4 |
bleeding on warfarin guidelines | 1.03 | 0.1 | 6606 | 73 |
risk factors for bleeding on warfarin | 1.78 | 0.2 | 1525 | 51 |
dabigatran side effects atrial fibrillation | 1.86 | 0.8 | 6050 | 34 |
is dabigatran a blood thinner | 1.15 | 0.1 | 3742 | 29 |
warfarin and heparin bridging | 0.66 | 0.1 | 8831 | 83 |
dabigatran dose for dvt | 1.82 | 0.5 | 5525 | 24 |
dabigatran drug interaction case report | 0.64 | 0.8 | 3223 | 21 |
dabigatran in cancer patients | 0.13 | 0.4 | 8360 | 54 |
heparin bridge to warfarin dvt | 0.6 | 0.6 | 7785 | 31 |
benefits and risks of dabigatran | 1.88 | 0.8 | 9187 | 24 |
warfarin bridging with heparin | 0.92 | 0.7 | 2427 | 43 |
other therapeutic effects for dabigatran | 0.21 | 0.6 | 5987 | 100 |